Recombinant; Rabbit anti Human PSMB10/MECL1 Antibody; WB, IHC; Unconjugated
| SKU | Size | Availability | Price | Qty |
|---|---|---|---|---|
| Ab123661-10μl | 10μl | In stock | $69.90 | |
| Ab123661-50μl | 50μl | In stock | $189.90 | |
| Ab123661-100μl | 100μl | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $299.90 | |
| Ab123661-1ml | 1ml | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $2,599.90 |
Recombinant; Rabbit anti Human PSMB10/MECL1 Antibody; WB, IHC; Unconjugated
| Product Name | Recombinant PSMB10/MECL1 Antibody - Primary antibody, specific to PSMB10/MECL1, Rabbit IgG |
|---|---|
| Synonyms | EC 3.4.25.1 | Low molecular mass protein 10 | Macropain subunit MECl-1 | Multicatalytic endopeptidase complex subunit MECl-1 | Proteasome MECl-1 | Proteasome subunit beta-2i | beta2i antibody | FLJ00366 antibody | LMP10 antibody | Low molecular mass prote |
| Specifications & Purity | ExactAb™, Validated, Recombinant, 0.6 mg/mL |
| Host species | Rabbit |
| Specificity | PSMB10/MECL1 |
| Immunogen | A synthetic peptide derived from human PSMB10 (AA 56-70) |
| Positive Control | WB: THP-1, Raji, A431 and C6 cell lysates. IHC: Human lung cancer tissue. |
| Conjugation | Unconjugated |
| Grade | ExactAb™, Recombinant, Validated |
| Product Description |
Rabbit anti Human PSMB10/MECL1 Antibody, Recombinant, could be used for WB, IHC and so on. |
| Isotype | Rabbit IgG |
|---|---|
| SDS-PAGE | 150 kDa |
| Purification Method | Antigen affinity purified |
| Form | Liquid |
| Concentration | 0.6 mg/mL |
| Storage Temp | Store at -20°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at 4℃ short term (1-2 weeks). Store at -20℃ long term (24 months). Upon delivery aliquot. Avoid freeze/thaw cycle. |
Recombinant PSMB10/MECL1 Antibody (Ab123661) - Western Blot
All lanes: Recombinant PSMB10/MECL1 Antibody (Ab123661) at 1/1000 dilution
Samples: Lysates at 20 µg per lane
Secondary: Goat Anti-Rabbit IgG H&L (HRP) (Ab170144) at 1/40000 dilution
Predicted band size: 29 kDa
Observed band size: 26, 29 kDa
Exposure time: 66.8 s
Recombinant PSMB10/MECL1 Antibody (Ab123661) - IHC
Immunohistochemistry analysis of paraffin-embedded Human lung cancer using Recombinant PSMB10/MECL1 Antibody (Ab123661). High-pressure and temperature Sodium Citrate pH 6.0 was used for antigen retrieval.
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Application | Dilution info |
|---|---|
| WB | 1/500-1/1000 |
| IHC | 1/50 - 1/100 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
 ZJ24F0303441 | Certificate of Analysis | Mar 20, 2024 | Ab123661 |
| ZJ24F0303442 | Certificate of Analysis | Mar 20, 2024 | Ab123661 |
| 1. Kuhn DJ, Chen Q, Voorhees PM, Strader JS, Shenk KD, Sun CM, Demo SD, Bennett MK, van Leeuwen FW, Chanan-Khan AA et al.. (2007) Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma.. Blood, 110 (9): (3281-90). [PMID:17591945] |
| 2. Fan H, Angelo NG, Warren JD, Nathan CF, Lin G. (2014) Oxathiazolones Selectively Inhibit the Human Immunoproteasome over the Constitutive Proteasome.. ACS Med Chem Lett, 5 (4): (405-10). [PMID:24900849] |
| 3. Johnson HWB, Lowe E, Anderl JL, Fan A, Muchamuel T, Bowers S, Moebius DC, Kirk C, McMinn DL. (2018) Required Immunoproteasome Subunit Inhibition Profile for Anti-Inflammatory Efficacy and Clinical Candidate KZR-616 ((2 S,3 R)- N-(( S)-3-(Cyclopent-1-en-1-yl)-1-(( R)-2-methyloxiran-2-yl)-1-oxopropan-2-yl)-3-hydroxy-3-(4-methoxyphenyl)-2-(( S)-2-(2-morpholinoacetamido)propanamido)propenamide).. J Med Chem, 61 (24): (11127-11143). [PMID:30380863] |
| 4. Xie SC, Gillett DL, Spillman NJ, Tsu C, Luth MR, Ottilie S, Duffy S, Gould AE, Hales P, Seager BA et al.. (2018) Target Validation and Identification of Novel Boronate Inhibitors of the Plasmodium falciparum Proteasome.. J Med Chem, 61 (22): (10053-10066). [PMID:30373366] |
| 5. de Bruin G, Huber EM, Xin BT, van Rooden EJ, Al-Ayed K, Kim KB, Kisselev AF, Driessen C, van der Stelt M, van der Marel GA, Groll M, Overkleeft HS.. (2014) Structure-based design of β1i or β5i specific inhibitors of human immunoproteasomes.. J Med Chem, 57 (14): (6197-6209). [PMID:25006746] |
| 6. Johnson HWB, Anderl JL, Bradley EK, Bui J, Jones J, Arastu-Kapur S, Kelly LM, Lowe E, Moebius DC, Muchamuel T, Kirk C, Wang Z, McMinn D.. (2017) Discovery of Highly Selective Inhibitors of the Immunoproteasome Low Molecular Mass Polypeptide 2 (LMP2) Subunit.. ACS Med Chem Lett, 8 (4): (413-417). [PMID:28435528] |
| 7. Schiffrer ES, Sosič I, Šterman A, Mravljak J, Raščan IM, Gobec S, Gobec M.. (2019) A focused structure-activity relationship study of psoralen-based immunoproteasome inhibitors.. Medchemcomm, 10 (11): (1958-1965). [PMID:32952997] |
| 8. Xin BT, Huber EM, de Bruin G, Heinemeyer W, Maurits E, Espinal C, Du Y, Janssens M, Weyburne ES, Kisselev AF, Florea BI, Driessen C, van der Marel GA, Groll M, Overkleeft HS.. (2019) Structure-Based Design of Inhibitors Selective for Human Proteasome β2c or β2i Subunits.. J Med Chem, 62 (3): (1626-1642). [PMID:30657666] |
| 9. Giżyńska M, Witkowska J, Karpowicz P, Rostankowski R, Chocron ES, Pickering AM, Osmulski P, Gaczynska M, Jankowska E.. (2019) Proline- and Arginine-Rich Peptides as Flexible Allosteric Modulators of Human Proteasome Activity.. J Med Chem, 62 (1): (359-370). [PMID:30452262] |
| 10. Long MJC, Lawson AP, Baggio R, Qian Y, Rozhansky L, Fasci D, El Oualid F, Weerapana E, Hedstrom L.. (2019) Diarylcarbonates are a new class of deubiquitinating enzyme inhibitor.. Bioorg Med Chem Lett, 29 (2): (204-211). [PMID:30528168] |
| 11. Zhang G,Li S,Wang F,Jones AC,Goldberg AFG,Lin B,Virgil S,Stoltz BM,Deshaies RJ,Chou TF. (2021) A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 and NMS-873 in colorectal cancer cells.. Eur J Med Chem, 213 (113148-113148). [PMID:33476933] |
| 12. Fiolek TJ,Magyar CL,Wall TJ,Davies SB,Campbell MV,Savich CJ,Tepe JJ,Mosey RA. (2021) Dihydroquinazolines enhance 20S proteasome activity and induce degradation of α-synuclein, an intrinsically disordered protein associated with neurodegeneration.. Bioorg Med Chem Lett, 36 (127821-127821). [PMID:33513387] |
| 13. Larsen, F F, Solheim, J J, Kristensen, T T, Kolstø, A B AB and Prydz, H H.. (1993) A tight cluster of five unrelated human genes on chromosome 16q22.1.. Human molecular genetics, [PMID:8268911] |
| 14. Hisamatsu, H H and 10 more authors.. (1996) Newly identified pair of proteasomal subunits regulated reciprocally by interferon gamma.. The Journal of experimental medicine, (1): [PMID:8666937] |
| 15. Foss, G S GS, Larsen, F F, Solheim, J J and Prydz, H H.. (1998) Constitutive and interferon-gamma-induced expression of the human proteasome subunit multicatalytic endopeptidase complex-like 1.. Biochimica et biophysica acta, (12): [PMID:9551082] |
| 16. Apcher, G Sébastien GS and 6 more authors.. (2003) Human immunodeficiency virus-1 Tat protein interacts with distinct proteasomal alpha and beta subunits.. FEBS letters, (9): [PMID:14550573] |
| 17. Raghavendra Prasad, H S HS, Qi, Z Z, Srinivasan, K N KN and Gopalakrishnakone, P P.. (2004) Potential effects of tetrodotoxin exposure to human glial cells postulated using microarray approach.. Toxicon : official journal of the International Society on Toxinology, [PMID:15501285] |
| 18. Namiki, Shin S and 8 more authors.. (2005) IRF-1 mediates upregulation of LMP7 by IFN-gamma and concerted expression of immunosubunits of the proteasome.. FEBS letters, (23): [PMID:15907481] |
| 19. Wu, Feng F and 8 more authors.. (2007) Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis.. Inflammatory bowel diseases, [PMID:17262812] |
| 20. Moschonas, Aristides A and 5 more authors.. (2008) CD40 induces antigen transporter and immunoproteasome gene expression in carcinomas via the coordinated action of NF-kappaB and of NF-kappaB-mediated de novo synthesis of IRF-1.. Molecular and cellular biology, [PMID:18694960] |
| 21. Van Damme, Petra P and 15 more authors.. (2012) N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.. Proceedings of the National Academy of Sciences of the United States of America, (31): [PMID:22814378] |
